Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

US Patent 11730746 · Granted Aug 22, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025